Sort
51,593 grants matching “hepatitis”
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
$699,884Ethan Perlstein · Maggie'S Pearl, Llc · R44 · FY2022 · DK
Non-esterified Fatty Acids and Cardiometabolic Disease in Older Adults
$699,815Luc Djousse · Brigham And Women'S Hospital · R01 · FY2017 · AG
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$699,766Luc Teyton · Scripps Research Institute, The · U01 · FY2021 · AI
Patient Navigator plus Remote mHealth Adherence Support with Incentives to Improve Linkage and Retention among Hospitalized Patients with Opioid and Methamphetamine Use Who Initiate Buprenorphine
$699,750Judith Tsui · University Of Washington · R34 · FY2022 · DA
In vivo HTS assay for novel modulators of Apolipoprotein B
$699,728Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2021 · DK
Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
$699,713Mark A Kay · Stanford University · R37 · FY2023 · AI
Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
$699,711Mark A Kay · Stanford University · R37 · FY2025 · AI
Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
$699,711Mark A Kay · Stanford University · R37 · FY2024 · AI
HIV AND THE SEXUAL NETWORKS OF IDUS AND DRUG-USING MSM
$699,701University Of Illinois At Chicago · U01 · FY2003 · DA
Metabolic Health during Puberty: the Healthy Start Study
$699,677Dana Dabelea · University Of Colorado Denver · R01 · FY2025 · DK
Metabolic Health during Puberty: the Healthy Start Study
$699,607Dana Dabelea · University Of Colorado Denver · R01 · FY2023 · DK
Impact on opioid use of bundling medication-assisted treatment with mHealth
$699,519David H Gustafson · University Of Wisconsin-Madison · R01 · FY2017 · DA
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$699,515Rohit Loomba · University Of California, San Diego · U01 · FY2022 · AA
Metabolic Health during Puberty: the Healthy Start Study
$699,478Dana Dabelea · University Of Colorado Denver · R01 · FY2022 · DK
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use
$699,461Shenghan Lai · Johns Hopkins University · R01 · FY2014 · DA
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans
$699,392Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2017 · HL
HIV Risk and Neighborhood Networks of New IDUs
$699,367Alan Neaigus · National Development And Research Institutes, Inc. · R01 · FY2006 · DA
Development of Novel Therapies or Methamphetamine Abuse
$699,330Linda P Dwoskin · University Of Kentucky · U01 · FY2015 · DA
Restoring Central Regulation of Glucose Production in Type 2 Diabetes
$699,257Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2023 · DK
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort
$699,107Marina Serper · University Of Pennsylvania · R01 · FY2023 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B
$699,003Stewart Cooper · California Pacific Med Ctr Res Institute · R01 · FY2019 · DK
The Impact of HCV Infection on Bone Turnover, Density, and Strength
$698,944Todd T Brown · Johns Hopkins University · R01 · FY2020 · AI
Serum Organochlorine Levels and Primary Liver Cancer: A Nested Case-Control Study
$698,926Jaya M Satagopan · Sloan-Kettering Inst Can Research · R01 · FY2009 · ES
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana
$698,829Lee Frederick Schroeder · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$698,781Michelle Van Name · Yale University · R01 · FY2024 · DK